79228-67-4

Basic information

• Product Name: Ethyl 2-(4-cyanophenoxy)butanoate
• Synonyms: Ethyl 2-(4-cyanophenoxy)butanoate
• CAS NO: 79228-67-4
• Molecular Weight: 233.267
• Mol File: 79228-67-4.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: Ethyl 2-(4-cyanophenoxy)butanoate(CAS DataBase Reference)
• NIST Chemistry Reference: Ethyl 2-(4-cyanophenoxy)butanoate(79228-67-4)
• EPA Substance Registry System: Ethyl 2-(4-cyanophenoxy)butanoate(79228-67-4)

Safety Data

• Hazardous Substances Data: 79228-67-4(Hazardous Substances Data)

Upstream product

• 767-00-0 4-cyanophenol 
• 533-68-6 2-bromobutyric acid ethyl ester 

Downstream Products

• 1263320-67-7 3-[3-fluoro-4-[methylsulfonyl]phenyl]-5-{1-[4-(5-isopropyl-1,2,4-oxadiazol-3-yl)phenoxy]propyl}-1,2,4-oxadiazole 
• 1263320-63-3 2-[3-fluoro-4-(methylthio)phenyl]-2-oxoethyl 2-[4-(5-isopropyl-1,2,4-oxadiazol-3-yl)phenoxy]butanoate 
• 1263320-64-4 3-[4-(1-{4-[3-Fluoro-4-(methylthio)phenyl]-1,3-oxazol-2-yl}propoxy)phenyl]-5-isopropyl-1,2,4-oxadiazole 
• 1263320-72-4 3-[4-(1-{4-[3-fluoro-4-(methylsulfonyl)phenyl]-1,3-oxazol-2-yl}propoxy)phenyl]-5-isopropyl-1,2,4-oxadiazole 
• 1263320-49-5 ethyl 2-{4-[amino(hydroxyimino)methyl]phenoxy}butanoate 
• 1263483-61-9 2-Fluoro-4-(2-{1-[4-(5-isopropyl-1,2,4-oxadiazol-3-yl)phenoxy]propyl}-1,3-oxazol-4-yl)benzoic acid 
• 1263483-60-8 3-(4-{1-[4-(4-Bromo-3-fluorophenyl)-1,3-oxazol-2-yl]propoxy}phenyl)-5-isopropyl-1,2,4-oxadiazole 
• 1263483-59-5 2-(4-Bromo-3-fluorophenyl)-2-oxoethyl 2-[4-(5-isopropyl-1,2,4-oxadiazol-3-yl)phenoxy]butanoate 
• 1263320-51-9 2-[4-(5-isopropyl-1,2,4-oxadiazol-3-yl)phenoxy]butyric acid 
• 1263320-50-8 ethyl 2-[4-(5-isopropyl-1,2,4-oxadiazol-3-yl)phenoxy]butanoate 

Relevant articles and documents

AMIDE DERIVATIVE

Provided are a compound having an excellent hypoglycemic action, or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition having an excellent therapeutic effect and/or prophylactic effect on type 1 diabetes, type 2 diabetes, and the like, which cause an increase in the blood sugar level due to abnormal sugar metabolism. A compound represented by general formula (I), or a pharmaceutically acceptable salt thereof, is disclosed.